Enveda Secures $311M Funding Round to Advance AI-Driven Nature-Derived Therapeutics
Biotechnology firm Enveda has successfully raised $311 million in a substantial new funding round, propelling the artificial intelligence drug discovery company to a valuation of $2 billion. The significant capital…
